查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631802

器官保存市场 - 全球产业规模、份额、趋势、机会和预测，按解决方案、技术、器官类型、最终用户、地区和竞争细分，2020-2030F

Organ Preservation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Solution, By Technique, By Organ Type, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球器官保存市场价值为 2.706 亿美元，预计到 2030 年预测期内将稳定增长，复合年增长率为 5.25%。然而，器官移植的成功在很大程度上取决于器官保存方法的效率。全球器官保存市场对于确保器官在捐赠和移植之间的关键时期的生存能力发挥着至关重要的作用。该领域的不断进步不仅扩大了可移植的器官数量，而且提高了移植手术的整体成功率。

市场概况
预测期 2026-2030
2024 年市场规模 2.706亿美元
2030 年市场规模 3.687亿美元
2025-2030年复合年增长率 5.25%
成长最快的细分市场 威斯康辛大学解决方案（UW 解决方案）
最大的市场 北美洲

器官衰竭和慢性疾病的日益普及导致全球器官移植手术的激增。因此，这增加了对先进器官保存解决方案的需求。器官保存技术的创新在扩大器官移植成功范围方面发挥了关键作用。低温保存技术、机器灌注和改进的保存解决方案等发展有助于取得更好的结果并提高捐赠器官的活力。人们对器官捐赠和保存重要性的认识不断提高，对公众的看法产生了积极影响。以器官保存为重点的教育活动和措施鼓励更多人成为器官捐赠者，从而促进了市场的整体成长。世界各国政府和监管机构已经认识到器官移植和保存的重要性。支持性政策和监管框架促进了先进器官保存技术的开发和商业化。

主要市场驱动因素

器官移植需求的成长正在推动全球器官保存市场。

不断增长的政府倡议和支持正在推动全球器官保存市场

主要市场挑战

器官可用性有限

主要市场趋势

技术进步

细分市场洞察

解决方案见解

最终使用者见解

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

  • 研究目的
  • 基线法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

第 4 章：全球器官保存市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按解决方案（威斯康辛大学解决方案（UW 解决方案）、Custodal HTK、Perfadex、其他解决方案）
    • 依技术分类（静态冷藏、低温机器灌注、常温机器灌注）
    • 依器官类型（肾臟、肝臟、肺臟、心臟、胰臟）
    • 按最终使用者（器官移植中心、医院、专科诊所）
    • 按地区
    • 按公司划分 (2024)
  • 市场地图
    • 按解决方案
    • 依技术
    • 依器官类型
    • 按最终用户
    • 按地区

第 5 章：亚太器官保存市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按解决方案
    • 依技术
    • 依器官类型
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国

第 6 章：欧洲器官保存市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按解决方案
    • 依技术
    • 依器官类型
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 西班牙
    • 义大利
    • 英国

第 7 章：北美器官保存市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按解决方案
    • 依技术
    • 依器官类型
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 8 章：南美洲器官保存市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按解决方案
    • 依技术
    • 依器官类型
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 9 章：中东和非洲器官保存市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按解决方案
    • 依技术
    • 依器官类型
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 10 章：市场动态

  • 司机
  • 挑战

第 11 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 12 章：全球器官保存市场：SWOT 分析

第 13 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第14章：竞争格局

  • Paragonix Technologies Inc.
  • XVIVO Perfusion AB
  • Dr. Franz Kohler Chemie GmbH
  • OrganOx Limited
  • Bridge to Life (Europe) Limited
  • Waters Medical Systems, LLC
  • Preservation Solutions Inc.
  • Artivion Inc.
  • Vascular Perfusion Solutions
  • Global Transplant Solutions

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 23227

Global Organ Preservation Market was valued at USD 270.60 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2030. Organ transplantation has emerged as a life-saving medical procedure for individuals suffering from end-stage organ failure. However, the success of organ transplantation relies heavily on the efficiency of organ preservation methods. The global organ preservation market plays a crucial role in ensuring the viability of organs during the critical period between donation and transplantation. Continuous advancements in this field are not only expanding the pool of transplantable organs but also enhancing the overall success rates of transplant procedures.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 270.60 Million
Market Size 2030USD 368.70 Million
CAGR 2025-20305.25%
Fastest Growing SegmentUniversity of Wisconsin Solution (UW Solution)
Largest MarketNorth America

The increasing prevalence of organ failure and chronic diseases has led to a surge in organ transplantation procedures worldwide. This has consequently boosted the demand for advanced organ preservation solutions. Innovations in organ preservation technologies have played a pivotal role in expanding the scope of successful organ transplantation. Developments such as hypothermic preservation techniques, machine perfusion, and improved preservation solutions have contributed to better outcomes and increased the viability of donated organs. Increased awareness regarding the importance of organ donation and preservation has positively influenced public perceptions. Education campaigns and initiatives focusing on organ preservation have encouraged more individuals to become organ donors, thereby contributing to the overall growth of the market. Governments and regulatory bodies around the world have recognized the significance of organ transplantation and preservation. Supportive policies and regulatory frameworks have facilitated the development and commercialization of advanced organ preservation technologies.

Key Market Drivers

Rising Demand for Organ Transplants is Driving the Global Organ Preservation Market.

The global organ preservation market is experiencing significant growth, propelled by the rising demand for organ transplants. Organ transplantation has emerged as a crucial solution for patients suffering from end-stage organ failure, and as the number of patients in need of transplants continues to rise, the demand for advanced organ preservation methods is becoming more pronounced. Organ transplantation has become a lifesaving medical procedure, offering hope to patients with failing organs such as the heart, lungs, liver, kidneys, and pancreas. The increasing prevalence of chronic diseases, advancements in surgical techniques, and a growing aging population contribute to the rising demand for organ transplants globally. As of September 2024, the waiting list for organ transplants reflects a significant demand across various categories. The majority of patients, 89,792, are in need of kidney transplants, followed by 9,424 individuals awaiting liver transplants. There are 850 patients listed for pancreas transplants, while 2,177 are in need of a kidney/pancreas combination. Additionally, 3,456 patients are waiting for heart transplants, 898 require lung transplants, and 240 are listed for other organs. This data underscores the critical need for organ donations to meet the growing demand.

However, the success of organ transplantation is highly dependent on the quality and viability of the donated organs. Patient survival rates following organ transplantation have seen remarkable success, with over 95% surviving one year post-transplant and over 83% maintaining survival beyond five years. The strongest graft survival outcomes have been observed in simultaneous pancreas-kidney (SPK) transplants, achieving 86% pancreas graft function and 93% kidney graft function at the one-year mark. This has led to a parallel surge in the demand for effective organ preservation technologies that can extend the preservation time, maintain organ function, and ultimately enhance transplant outcomes. In recent years, significant strides have been made in the field of organ preservation technology. Traditional methods, such as cold storage, have been supplemented and, in some cases, replaced by more advanced techniques like hypothermic machine perfusion and normothermic machine perfusion.

Diseases such as diabetes, cardiovascular disorders, and chronic kidney diseases contribute to the growing pool of potential transplant recipients. Ongoing research and development efforts are resulting in the introduction of more advanced and efficient organ preservation technologies. Global initiatives to raise awareness about organ donation are positively impacting the availability of organs for transplantation. The establishment of transplant programs and centers in various regions is boosting the overall organ transplant market.

Growing Government Initiatives and Support is Driving the Global Organ Preservation Market

Organ preservation is a critical aspect of modern medicine, playing a pivotal role in organ transplantation procedures. As the demand for organ transplants continues to rise globally, governments around the world are stepping up their efforts to support and drive advancements in organ preservation technologies. These initiatives are not only improving the success rates of transplant procedures but also addressing the challenges of organ shortage. Recognizing the urgency of the situation, governments worldwide have initiated programs and policies to address organ shortages and improve organ preservation methods. Financial support, research grants, and regulatory frameworks have been established to incentivize innovation in the field of organ preservation.

Governments are allocating substantial funds to support research and development in organ preservation technologies. These funds are aimed at fostering collaborations between research institutions, universities, and private enterprises to accelerate the development of cutting-edge preservation techniques. Regulatory bodies are actively engaging with the industry to streamline approval processes for new organ preservation solutions. This support ensures that innovative technologies reach the market faster, benefiting both patients and the healthcare system. Governments are investing in public awareness campaigns to encourage organ donation. By educating the public about the importance of organ donation, these initiatives aim to increase the pool of available organs for transplantation. Recognizing that organ shortages are a global challenge, governments are fostering international collaboration. This includes sharing best practices, research findings, and resources to advance organ preservation technologies on a global scale.

Key Market Challenges

Limited Organ Availability

Limited organ availability stands out as a major challenge confronting the Global Organ Preservation Market. Several factors contribute to this shortage, creating a complex web of issues that impact the overall efficiency of organ transplantation processes. The demand for transplantable organs far exceeds the available supply. Organs suitable for transplantation are often rare, and the number of patients in need of a transplant continues to rise globally. This supply-demand imbalance is a persistent issue that the organ preservation market grapples with. The effective preservation and transportation of organs require robust logistical and infrastructural support. Developing regions may face challenges in establishing and maintaining the necessary facilities, leading to delays and potential wastage of viable organs.

Legal and ethical considerations surrounding organ donation and transplantation can vary across regions and cultures. These complexities can result in delays in the identification and allocation of suitable organs, further limiting their availability for preservation and transplantation. A lack of awareness and education about organ donation and the transplantation process contributes to a lower rate of voluntary organ donation. Increasing public awareness and fostering a positive attitude towards organ donation are crucial steps in addressing the organ shortage issue. The development and adoption of advanced organ preservation technologies require significant financial investment. Some regions may face constraints in adopting state-of-the-art preservation solutions, affecting the overall effectiveness of organ preservation methods.

Key Market Trends

Technological Advancements

In recent years, the field of organ preservation has witnessed a remarkable transformation, thanks to the rapid pace of technological advancements. As the demand for organ transplantation continues to rise globally, the need for effective preservation methods becomes increasingly critical. The Global Organ Preservation Market is experiencing a surge in growth, driven by innovative technologies that enhance the preservation of organs, improve transplantation outcomes, and address the persistent challenge of organ shortage. One of the breakthroughs in organ preservation is the adoption of hypothermic machine perfusion. This technique involves pumping a cold preservation solution through the organ, maintaining a lower temperature and supplying oxygen to the tissues. HMP has proven to be particularly effective for preserving organs such as kidneys, livers, and hearts, resulting in improved organ function post-transplant. Researchers have developed an innovative system designed to extend the transportation time for donor organs by simulating conditions that mimic their presence within the human body. This advanced technology maintains the flow of oxygenated blood through the organs, effectively delaying tissue degradation. While pending regulatory approval, this system has the potential to address a critical challenge in ensuring the safe and viable transportation of donor organs.

Normothermic machine perfusion is another cutting-edge technology that has gained traction in the organ preservation market. Unlike HMP, NMP preserves organs at or near body temperature, closely mimicking the physiological conditions of the human body. This approach is particularly promising for preserving livers and lungs, as it allows for continuous monitoring and assessment of the organ's function. Cryopreservation involves freezing organs at extremely low temperatures for long-term storage. Although challenging due to potential damage to cells during the freezing and thawing process, advancements in cryoprotectant solutions and techniques have made this method more viable. Cryopreservation has the potential to revolutionize organ transplantation by enabling the creation of organ banks for long-term storage. The integration of artificial intelligence into organ preservation systems has brought about a new era of personalized and adaptive solutions. AI algorithms can analyze real-time data from the perfusion process, predict potential issues, and adjust parameters to optimize organ preservation conditions. This level of precision contributes to better organ quality and transplant success rates.

Segmental Insights

Solution Insights

Based on the category of Solution, University of Wisconsin Solution (UW Solution) emerged as the dominant in the global market for Organ Preservation in 2024. UW Solution provides an optimal environment for organ preservation by preventing cellular damage during the storage period. Its unique composition helps maintain the delicate balance of electrolytes and nutrients necessary for cellular function. One of the significant advantages of UW Solution is its ability to extend the preservation time of organs. This is particularly crucial for organs that require longer transport times between the donor and recipient, enhancing the geographical reach of transplantation programs. UW Solution has proven effective for preserving various organs, including the liver, kidneys, pancreas, and intestines. Its versatility has contributed to its widespread adoption across different organ transplant procedures. Numerous clinical studies and real-world transplant cases have demonstrated the superior outcomes associated with the use of UW Solution. The solution has been instrumental in improving graft survival rates and overall transplant success.

End user Insights

The Organ Transplant Centers segment is projected to experience rapid growth during the forecast period. The rising prevalence of organ failure and an aging population have led to a surge in organ transplantation procedures, driving the demand for effective preservation methods. Continuous advancements in organ preservation technologies, such as machine perfusion and cryopreservation, are attracting organ transplant centers seeking to improve transplant outcomes. Supportive government policies and initiatives aimed at promoting organ transplantation and improving healthcare infrastructure are bolstering the growth of the organ preservation market. Growing investments in research and development activities by both public and private entities are fueling innovation in organ preservation methods, with organ transplant centers serving as key contributors.

Regional Insights

North America emerged as the dominant region in the global Organ Preservation market in 2024, holding the largest market share in terms of value. North America has been at the forefront of developing and implementing cutting-edge technologies in the organ preservation sector. The region has seen significant investments in research and development, resulting in the creation of advanced organ preservation solutions. These solutions aim to enhance the viability and longevity of organs during the transplantation process, ultimately improving patient outcomes. Innovative preservation methods, such as hypothermic and normothermic machine perfusion, have gained traction in North America. These methods enable the preservation of organs under conditions that closely mimic the body's natural environment, allowing for better organ quality and increased success rates in transplant procedures.

Key Market Players

  • Paragonix Technologies, Inc
  • XVIVO Perfusion AB
  • Dr. Franz Kohler Chemie GmbH
  • OrganOx Limited
  • Bridge to Life (Europe) Ltd.
  • Waters Medical Systems, LLC
  • Preservation Solutions Inc.
  • Artivion, Inc
  • Vascular Perfusion Solutions, Inc
  • Global Transplant Solutions

Report Scope:

In this report, the Global Organ Preservation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Preservation Market, By Solution:

  • University of Wisconsin Solution (UW Solution)
  • Custodial HTK
  • Perfadex
  • Other Solutions

Organ Preservation Market, By Technique:

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion

Organ Preservation Market, By Organ Type:

  • Kidney
  • Liver
  • Lung
  • Heart
  • Pancreas

Organ Preservation Market, By End User:

  • Organ Transplant Centers
  • Hospitals
  • Specialty Clinics

Organ Preservation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Organ Preservation Market.

Available Customizations:

Global Organ Preservation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Method

  • 2.1. Objective of the Study
  • 2.2. Baseline Method
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Method
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Organ Preservation Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Solution (University of Wisconsin Solution (UW Solution), Custodial HTK, Perfadex, Other Solutions)
    • 4.2.2. By Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion)
    • 4.2.3. By Organ Type (Kidney, Liver, Lung, Heart, Pancreas)
    • 4.2.4. By End User (Organ Transplant Centers, Hospitals, Specialty Clinics)
    • 4.2.5. By Region
    • 4.2.6. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Solution
    • 4.3.2. By Technique
    • 4.3.3. By Organ Type
    • 4.3.4. By End User
    • 4.3.5. By Region

5. Asia Pacific Organ Preservation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Solution
    • 5.2.2. By Technique
    • 5.2.3. By Organ Type
    • 5.2.4. By End User
    • 5.2.5. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Organ Preservation Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Solution
        • 5.3.1.2.2. By Technique
        • 5.3.1.2.3. By Organ Type
        • 5.3.1.2.4. By End User
    • 5.3.2. India Organ Preservation Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Solution
        • 5.3.2.2.2. By Technique
        • 5.3.2.2.3. By Organ Type
        • 5.3.2.2.4. By End User
    • 5.3.3. Australia Organ Preservation Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Solution
        • 5.3.3.2.2. By Technique
        • 5.3.3.2.3. By Organ Type
        • 5.3.3.2.4. By End User
    • 5.3.4. Japan Organ Preservation Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Solution
        • 5.3.4.2.2. By Technique
        • 5.3.4.2.3. By Organ Type
        • 5.3.4.2.4. By End User
    • 5.3.5. South Korea Organ Preservation Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Solution
        • 5.3.5.2.2. By Technique
        • 5.3.5.2.3. By Organ Type
        • 5.3.5.2.4. By End User

6. Europe Organ Preservation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Solution
    • 6.2.2. By Technique
    • 6.2.3. By Organ Type
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Organ Preservation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Solution
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Organ Type
        • 6.3.1.2.4. By End User
    • 6.3.2. Germany Organ Preservation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Solution
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Organ Type
        • 6.3.2.2.4. By End User
    • 6.3.3. Spain Organ Preservation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Solution
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Organ Type
        • 6.3.3.2.4. By End User
    • 6.3.4. Italy Organ Preservation Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Solution
        • 6.3.4.2.2. By Technique
        • 6.3.4.2.3. By Organ Type
        • 6.3.4.2.4. By End User
    • 6.3.5. United Kingdom Organ Preservation Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Solution
        • 6.3.5.2.2. By Technique
        • 6.3.5.2.3. By Organ Type
        • 6.3.5.2.4. By End User

7. North America Organ Preservation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Solution
    • 7.2.2. By Technique
    • 7.2.3. By Organ Type
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Organ Preservation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Solution
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Organ Type
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Organ Preservation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Solution
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Organ Type
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Organ Preservation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Solution
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Organ Type
        • 7.3.3.2.4. By End User

8. South America Organ Preservation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Solution
    • 8.2.2. By Technique
    • 8.2.3. By Organ Type
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Organ Preservation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Solution
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Organ Type
        • 8.3.1.2.4. By End User
    • 8.3.2. Argentina Organ Preservation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Solution
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Organ Type
        • 8.3.2.2.4. By End User
    • 8.3.3. Colombia Organ Preservation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Solution
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Organ Type
        • 8.3.3.2.4. By End User

9. Middle East and Africa Organ Preservation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Solution
    • 9.2.2. By Technique
    • 9.2.3. By Organ Type
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Organ Preservation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Solution
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Organ Type
        • 9.3.1.2.4. By End User
    • 9.3.2. Saudi Arabia Organ Preservation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Solution
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Organ Type
        • 9.3.2.2.4. By End User
    • 9.3.3. UAE Organ Preservation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Solution
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Organ Type
        • 9.3.3.2.4. By End User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Organ Preservation Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Paragonix Technologies Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Product & Services
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. XVIVO Perfusion AB
  • 14.3. Dr. Franz Kohler Chemie GmbH
  • 14.4. OrganOx Limited
  • 14.5. Bridge to Life (Europe) Limited
  • 14.6. Waters Medical Systems, LLC
  • 14.7. Preservation Solutions Inc.
  • 14.8.Artivion Inc.
  • 14.9.Vascular Perfusion Solutions
  • 14.10.Global Transplant Solutions

15. Strategic Recommendations

16. About us & Disclaimer